GE Wins Arbitration Against ABI in Licensing Dispute; ABI to Record $20M Charge in Fiscal Q1 | GenomeWeb

NEW YORK, Nov. 7 (GenomeWeb News) - Applied Biosystems said last week that an arbitrator has sided with Amersham Biosciences, now GE Healthcare, in the companies' dispute over a licensing agreement related to DNA sequencing reagents and kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.